These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4703952)

  • 1. The impact of radioimmunoassay for hepatitis B antigen on blood banking and transfusion practices in Wisconsin.
    Becker GA; Aster RH
    Wis Med J; 1973 May; 72(5):138. PubMed ID: 4703952
    [No Abstract]   [Full Text] [Related]  

  • 2. The Australia antigen and blood transfusion.
    Gocke DJ
    Vox Sang; 1970; 19(3):327-31. PubMed ID: 4993784
    [No Abstract]   [Full Text] [Related]  

  • 3. AABB reacts to rise in hepatitis rates.
    Hospitals; 1971 Nov; 45(22):67-70. PubMed ID: 5128764
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Hepatitis B antigen in screened blood units.
    Can Med Assoc J; 1974 May; 110(9):1008 passim. PubMed ID: 4823103
    [No Abstract]   [Full Text] [Related]  

  • 5. non-A, Non-B hepatitis. II. Experimental transmission, putative virus agents and markers, and prevention.
    Dienstag JL
    Gastroenterology; 1983 Sep; 85(3):743-68. PubMed ID: 6307808
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood banking services.
    Hartney JB
    Hospitals; 1972 Apr; 46(7):62-5. PubMed ID: 4552330
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B antigen: new technics for the reduction of posttransfusion hepatitis.
    Gitnick GL; Koretz RL
    Am J Gastroenterol; 1974 May; 61(5):366-70. PubMed ID: 4835933
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction of hepatitis B seroprevalence in blood banking units by combined utilization of self-exclusion forms and clinical evaluation of blood donation candidates in Turkey.
    Yenicesu I; Dilsiz G; Oztürk G
    Trop Doct; 2008 Apr; 38(2):112-3. PubMed ID: 18453509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of Australia antigen by radioimmunoassay (comparative study of the accuracy of this method by counter-electrophoresis)].
    Esztergalyos J; Dabasi G; Mezei I
    Orv Hetil; 1974 Feb; 115(7):376-8. PubMed ID: 4839148
    [No Abstract]   [Full Text] [Related]  

  • 11. [Decrease of transfusion hepatitis following introduction of transaminases and Australia (SH)-antigen determination in blood donors].
    Arndt HJ; Frese R; Nachtwey K; Loos W; Kaboth U; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Aug; 96(34):1371-2. PubMed ID: 4998053
    [No Abstract]   [Full Text] [Related]  

  • 12. Viral hepatitis and the Australia antigen.
    Borst-Eilers E
    Folia Med Neerl; 1970; 13(5):166-70. PubMed ID: 4923492
    [No Abstract]   [Full Text] [Related]  

  • 13. Viral hepatitis.
    Br Med J; 1972 Jun; 2(5815):669-70. PubMed ID: 5031706
    [No Abstract]   [Full Text] [Related]  

  • 14. [Currently available means for the prevention of post-transfusion hepatitis and criteria for their application].
    Bedarida G; Cambiè G; D'Agostino F; Sterza G
    Ric Clin Lab; 1984; 14 Suppl 1():37-60. PubMed ID: 6429830
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-HBc and post-transfusion hepatitis B. Problems pending solution].
    Acero D; Profitós J; Martí MJ; Palomer J; Caballería J; Bruguera M
    Med Clin (Barc); 1984 May; 82(20):910-1. PubMed ID: 6748797
    [No Abstract]   [Full Text] [Related]  

  • 16. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
    Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K
    Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of hepatitis-associated antigen in a Toronto hospital.
    Givan KF; Wong K
    Can Med Assoc J; 1971 Sep; 105(6):602 passim. PubMed ID: 5000822
    [No Abstract]   [Full Text] [Related]  

  • 18. AABB-CAP survey data on hepatitis--incidence, surveillance, and prevention.
    Polesky HF; Hanson M
    Am J Clin Pathol; 1980 Oct; 74(4 Suppl):565-8. PubMed ID: 7435449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosurveillance of transfusion dependent thalassaemia and hepatitis B vaccination.
    Mazumder M; Sengupta B; De M; Lahiri P; Bhattacharya DK
    J Assoc Physicians India; 1993 Jun; 41(6):342-4. PubMed ID: 8005968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radioimmunoassay of E antigen and anti-E antibody system of hepatitis B virus].
    Novak I; Kselikova M; Urbankova I
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):55-7. PubMed ID: 7088919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.